000963 華東醫藥
按盤價 
42.730 -0.300 (-0.697%)
42.730 -0.300 (-0.697%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.882 | 15.925 | 14.328 | 14.217 | 14.754 |
| 總資產報酬率 ROA (%) | 2.366 | 9.839 | 8.775 | 8.590 | 8.991 |
| 投入資產回報率 ROIC (%) | 3.106 | 13.047 | 11.916 | 11.856 | 12.571 | 邊際利潤分析 |
| 銷售毛利率 (%) | 32.873 | 33.211 | 32.400 | 31.903 | 30.686 |
| 營業利潤率 (%) | 10.547 | 10.320 | 8.500 | 8.117 | 8.262 |
| 息稅前利潤/營業總收入 (%) | 10.428 | 10.318 | 8.658 | 8.245 | 8.245 |
| 淨利潤/營業總收入 (%) | 8.513 | 8.338 | 7.007 | 6.715 | 6.766 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.980 | 102.585 | 102.189 | 103.790 | 100.298 |
| 價值變動淨收益/利潤總額(%) | -3.858 | -3.003 | -6.736 | -3.731 | -3.406 |
| 營業外收支淨額/利潤總額(%) | -2.471 | -0.540 | 0.377 | -1.001 | -0.997 | 償債能力分析 |
| 流動比率 (X) | 1.561 | 1.526 | 1.712 | 1.730 | 1.671 |
| 速動比率 (X) | 1.213 | 1.180 | 1.315 | 1.288 | 1.242 |
| 資產負債率 (%) | 37.733 | 37.792 | 35.593 | 38.522 | 37.246 |
| 帶息債務/全部投入資本 (%) | 18.385 | 18.143 | 13.552 | 14.209 | 11.904 |
| 股東權益/帶息債務 (%) | 434.552 | 441.461 | 620.086 | 578.494 | 712.153 |
| 股東權益/負債合計 (%) | 161.643 | 161.087 | 176.469 | 154.613 | 164.885 |
| 利息保障倍數 (X) | 76.588 | 194.199 | 68.709 | 39.733 | 129.087 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 83.763 | 68.213 | 64.930 | 65.048 | 65.453 |
| 存貨周轉天數 (天) | 61.003 | 58.309 | 57.587 | 59.364 | 60.424 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 25/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
